Health Promotion and Disease Prevention Research Centers: 2024 Special Interest Project Competitive Supplements (SIPS)-South Carolina Cancer Prevention and Control Research Network IV
- Institution
- University of South Carolina at Columbia, SC
- Principal investigator
- Swann Arp Adams
- Funding
- $300K
- Duration
- 2024–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT Cancer-related health disparities in South Carolina (SC) are among the largest in the nation. The South Carolina Cancer Prevention and Control Research Network (SC-CPCRN) is currently one of nine Centers for Disease Control and Prevention (CDC) and National Cancer Institute (NCI)-funded Collaborating Centers working to reduce cancer-related health disparities among disenfranchised and medically underserved populations by advancing dissemination and implementation (D&I) science. In strong partnership with the South Carolina Cancer Alliance; federally qualified health centers; and other academic, clinical, community, and faith-based partners, the SC-CPCRN uses evidence-based approaches for the D&I of efficacious cancer prevention and control messages, guidelines, and interventions. The relevance of our D&I efforts in SC is strengthened considerably through established partnerships with our target audiences and stakeholders in both urban and rural regions, leading to improved health outcomes. Our team’s well-recognized community- engaged research approach to D&I science and community-clinical linkages increase the validity and relevance of our work, ultimately providing all stakeholders with valuable information about strategies and programming for improving health and reducing cancer-related health disparities. This work is guided by the latest D&I science and national cancer research priorities. These priorities include (1) Healthy People 2030 objectives to increase cancer screening rates, decrease mortality, and increase survival; (2) National Center for Chronic Disease Prevention and Health Promotion’s approach to the social determinants of health; (3) NCI’s emphasis on rural cancer control; and (4) Blue Ribbon Panel recommendations of the Cancer Moonshot focused on “expanding development and implementation of evidence-based interventions to reduce cancer risk and cancer-related disparities”. We will utilize existing local and regional organizational infrastructure and strong partnerships and will continue to encourage new linkages between community and clinical partners for our center-specific and cross-center D&I initiatives. Our Specific Aims are to: 1) Disseminate, implement, and evaluate efficacious, multi-level, and multi-site public health, cancer control interventions to address cancer-related health disparities; 2) Engage community and clinical partners in research, training, and technical assistance to strengthen D&I science for cancer control in SC and nationally, and translate effective community-based interventions for cancer prevention and screening into practice; and, 3) Increase the capacity of community and clinical partners in the D&I of evidence-based cancer control strategies for reaching underserved, minority, and rural populations.
Research team
- Swann Arp AdamsPI
- Sara WilcoxPI
LOADING MOONBASE SCORE
Questions for University of South Carolina at Columbia
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of South Carolina at ColumbiaNot yet scored
Optimizing and Projecting Lifestyle Behavioral Interventions to Sustain Long-term Health Behaviors and Outcomes in Focus Populations
Brian Chen · $499K · 2025–2029
- NIH · University of South Carolina at ColumbiaNot yet scored
Examination of the Dose Response Relationship Between Physical Activity and Arthritis-Attributable Outcomes
Christine Ann Pellegrini · $250K · 2024–2026
- NIH · University of South Carolina at ColumbiaNot yet scored
A Systems Theory Approach to the Study of Colon and Lung Cancer Survivorship Using Novel Data Linkages
Swann Arp Adams · $335K · 2024–2029